Literature DB >> 15224374

Childhood acute myeloid leukemia with CBFbeta-MYH11 rearrangement: study of incidence, morphology, cytogenetics, and clinical outcomes of Chinese in Hong Kong.

Natalie P H Chan1, W S Wong, Margaret H L Ng, K S Tsang, T T Lau, Yonna Leung, K W Chik, Mathew M K Shing, C K Li.   

Abstract

We analyzed 43 consecutive cases of pediatric acute myeloid leukemia (AML) for the presence of the CBFbeta-MYH11 rearrangement using molecular techniques in a regional hospital in Hong Kong. Five cases (11.6%), 3 girls and 2 boys, ranging in age from 8 months to 14 years old, were found positive for the CBFbeta-MYH11 rearrangement. Morphologically, they were FAB M2 or M4 with or without eosinophilia (Eo). Typical M4Eo was observed in only one case. The molecular findings were in complete concordance with cytogenetic data, which revealed inv(16)(p13q22) in all and also gains of chromosome 4, 8, 22, and Y in one patient. Clinically, all 5 patients achieved complete remission after chemotherapy with favorable outcomes except for the patient with infantile AML, who relapsed 11 months after diagnosis, underwent cord blood transplantation, and was in second remission. This is the first clinicopathological study and documentation of the incidence of CBFbeta-MYH11 in childhood AML of Chinese in Hong Kong. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15224374     DOI: 10.1002/ajh.20081

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.

Authors:  Gaoqi Zhang; Jinlong Shi; Xinrui Yang; Xinpei Zhang; Lingxiu Zhang; Jilei Zhang; Siyuan Yang; Jing Wang; Kai Hu; Xiaoyan Ke; Lin Fu
Journal:  Oncol Lett       Date:  2019-04-15       Impact factor: 2.967

Review 2.  Global characteristics of childhood acute promyelocytic leukemia.

Authors:  L Zhang; A Samad; M S Pombo-de-Oliveira; G Scelo; M T Smith; J Feusner; J L Wiemels; C Metayer
Journal:  Blood Rev       Date:  2014-09-30       Impact factor: 8.250

3.  A Case of Acute Myeloid Leukemia (FAB M2) with Inversion 16 Who Presented with Pelvic Myeloid Sarcoma.

Authors:  Mustafa Çakan; Ahmet Koç; Kıvılcım Cerit; Süheyla Bozkurt; Rabia Ergelen; Irmak Vural
Journal:  Case Rep Pediatr       Date:  2014-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.